for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Johnson & Johnson

JNJ

Latest Trade

143.35USD

Change

-1.09(-0.75%)

Volume

1,824,100

Today's Range

143.34

 - 

144.84

52 Week Range

109.16

 - 

157.00

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
144.44
Open
144.56
Volume
1,824,100
3M AVG Volume
129.06
Today's High
144.84
Today's Low
143.34
52 Week High
157.00
52 Week Low
109.16
Shares Out (MIL)
2,632.82
Market Cap (MIL)
379,679.50
Forward P/E
18.33
Dividend (Yield %)
2.80

Next Event

Q3 2020 Johnson & Johnson Earnings Release

Latest Developments

More

J&J, On Covid-19 Says Like Many Organizations, We Are Evaluating Potential Benefit Of A Human Challenge Trials

Janssen Shows Findings From Global, Multi-Center Trial Examining Amivantamab In Combination With Lazertinib In Patients With EGFR-Mutated Non-Small Cell Lung Cancer

Johnson & Johnson Says XWPharma Completes $40 Mln Financing and Appoints Leonard Blum as CEO

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Industry

Biotechnology & Drugs

Contact Info

1 Johnson And Johnson Plz

NEW BRUNSWICK, NJ

08933-0001

United States

+1.732.5242455

https://www.jnj.com/

Executive Leadership

Alex Gorsky

Chairman of the Board, Chief Executive Officer

Paulus A. Stoffels

Vice Chairman- Executive Committee, Chief Scientific Officer

Joaquin Boix Duato

Vice Chairman - Executive Committee

Joseph J. Wolk

Chief Financial Officer, Executive Vice President

Peter M. Fasolo

Chief Human Resource Officer, Executive Vice President

Key Stats

1.94 mean rating - 18 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

76.5K

2018

81.6K

2019

82.1K

2020(E)

80.6K
EPS (USD)

2017

7.300

2018

8.180

2019

8.680

2020(E)

7.867
Price To Earnings (TTM)
25.87
Price To Sales (TTM)
4.72
Price To Book (MRQ)
6.03
Price To Cash Flow (TTM)
17.34
Total Debt To Equity (MRQ)
48.26
LT Debt To Equity (MRQ)
39.79
Return on Investment (TTM)
12.13
Return on Equity (TTM)
9.50

Latest News

Latest News

J&J kicks off study of single-shot COVID-19 vaccine in 60,000 volunteers

Johnson & Johnson <JNJ.N> on Wednesday began a 60,000-person trial of an experimental single-shot COVID-19 vaccine that, if proven effective, could simplify distribution of millions of doses compared with leading rivals requiring two doses.

J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers

Johnson & Johnson on Wednesday kicked off a final 60,000-person trial of a single-shot COVID-19 vaccine that potentially would simplify distribution of millions of doses compared with leading rivals using two doses.

Genmab shares drop on legal battle with J&J over cancer drug

Shares in Danish biotech firm Genmab <GMAB.CO> fell as much as 14% on Wednesday after it said it was locked in a legal battle with its partner Johnson & Johnson <JNJ.N> over royalty payments for its key cancer drug.

FACTBOX-EU tries to catch-up after U.S., UK spend billions to secure coronavirus vaccines

(Adds ReiThera; updates Sanofi, AstraZeneca, Novavax, Johnson & Johnson) Sept 21 (Reuters) - The United States and United Kingdom are leading a rush to strike deals with drugmakers to reserve supplies of experimental coronavirus vaccines. The European Union also signed its...

Trump suggests Pfizer could win U.S. COVID-19 vaccine approval, JNJ to come later

U.S. President Donald Trump on Monday suggested Pfizer Inc could secure the first U.S. approval of a COVID-19 vaccine in coming weeks, saying a contender by Johnson & Johnson could come later.

Johnson & Johnson charged by New York with civil insurance fraud over opioid claims

New York state filed civil charges on Thursday accusing Johnson & Johnson of insurance fraud for downplaying the risks of opioid painkillers, including to doctors and elderly patients.

New York charges Johnson & Johnson with insurance fraud over opioid claims

New York state filed civil charges on Thursday accusing Johnson & Johnson of insurance fraud for downplaying the risks of opioid painkillers, including to elderly patients.

Some volunteers quit J&J COVID-19 trial in Spain after AstraZeneca scare: investigator

Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.

Some back out of J&J COVID-19 vaccine trial in Spain after AstraZeneca scare, lead investigator says

News of serious side effects in one participant of AstraZeneca's COVID-19 vaccine trial led some volunteers in Johnson & Johnson's vaccine trial in Spain to drop out, its lead investigator told Reuters on Tuesday.

J&J unit to start mid-stage COVID-19 vaccine trials in Spain

Johnson & Johnson's <JNJ.N> Janssen unit will begin mid-stage trials of its COVID-19 vaccine in Spain on Monday, the programme's lead investigator said.

Exclusive: J&J seeking one-third of COVID-19 vaccine trial volunteers in hard-hit Latin America

Johnson & Johnson <JNJ.N> will seek 20,000 volunteers for late-stage human trials of its experimental coronavirus vaccine in hard-hit Latin America, one-third of the planned global total, one of its public health chiefs in the region said.

J&J's coronavirus vaccine candidate prevents severe disease in hamsters

Johnson & Johnson <JNJ.N> said on Thursday its experimental coronavirus vaccine prevented hamsters from getting severely ill, as the drugmaker seeks to begin large, late-stage studies in humans later this month.

Canada wants to be at 'front of line' for coronavirus vaccines, signs deals with Novavax and Johnson & Johnson

Canada reached an agreement in principle on Monday with both Novavax Inc <NVAX.O> and Johnson & Johnson <JNJ.N> for millions of doses of their experimental coronavirus vaccines, Prime Minister Justin Trudeau said.

FACTBOX-Dozens of countries host clinical trials of coronavirus vaccine candidates

As the race to develop a safe and effective coronavirus vaccine reaches its final stages, pharmaceutical companies have started conducting large human trials in different countries. Some countries also have signed supply deals with the companies. Below is a summary of clinical...

J&J to start mid-stage coronavirus vaccine trials in three European countries

Johnson & Johnson's <JNJ.N> Janssen unit will begin mid-stage trials for its coronavirus vaccine in Spain, the Netherlands and Germany next week, Spain's health minister said on Friday, as the U.S. drugmaker expands testing for its experimental shot.

CORRECTED (OFFICIAL)-J&J's Janssen to begin Phase II COVID-19 vaccine trials next week in Spain

Johnson & Johnson's Janssen unit will begin Phase II trials for its COVID-19 vaccine in Spain, the Netherlands and Germany next week, Spanish health minister Salvador Illa announced on Friday, as the U.S. drugmaker expands testing for its experimental shot.

J&J adds Chile, Argentina and Peru to Latin America COVID-19 vaccine trials

U.S. pharmaceutical company Johnson & Johnson has added Chile, Argentina and Peru to the Latin nations where it plans to conduct Phase III trials for its vaccine against COVID-19, the company confirmed on Wednesday.

REFILE-J&J adds Chile and Peru to Latin America COVID-19 vaccine trials

U.S. pharmaceutical company Johnson & Johnson has added Chile and Peru to the Latin nations where it plans to conduct Phase III trials for its vaccine against COVID-19, a university researcher said on Wednesday.

FDA drops boxed warning from Johnson & Johnson's diabetes drug label

The U.S. Food and Drug Administration on Wednesday removed a boxed warning about increased risk of leg and foot amputations with Johnson & Johnson's diabetes drug Invokana.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up